Imaging Methods to Evaluate Tumor Microenvironment Factors Affecting Nanoparticle Drug Delivery and Antitumor Response

Overview

Journal Cancer Drug Resist

Date 2021 Nov 19

PMID 34796317

Citations 7

Authors

Amber S Moody

Paul A Dayton

William C Zamboni

Affiliations

Soon will be listed here.

Abstract

Standard small molecule and nanoparticulate chemotherapies are used for cancer treatment; however, their effectiveness remains highly variable. One reason for this variable response is hypothesized to be due to nonspecific drug distribution and heterogeneity of the tumor microenvironment, which affect tumor delivery of the agents. Nanoparticle drugs have many theoretical advantages, but due to variability in tumor microenvironment (TME) factors, the overall drug delivery to tumors and associated antitumor response are low. The nanotechnology field would greatly benefit from a thorough analysis of the TME factors that create these physiological barriers to tumor delivery and treatment in preclinical models and in patients. Thus, there is a need to develop methods that can be used to reveal the content of the TME, determine how these TME factors affect drug delivery, and modulate TME factors to increase the tumor delivery and efficacy of nanoparticles. In this review, we will discuss TME factors involved in drug delivery, and how biomedical imaging tools can be used to evaluate tumor barriers and predict drug delivery to tumors and antitumor response.

Citing Articles

Single-cell spatial immune profiling for precision immunotherapy in Lynch syndrome.

Chambuso R, Meena S J Natl Cancer Cent. 2025; 5(1):3-7.

PMID: 40040872 PMC: 11873620. DOI: 10.1016/j.jncc.2024.12.002.

Converging frontiers in cancer treatment: the role of nanomaterials, mesenchymal stem cells, and microbial agents-challenges and limitations.

Afkhami H, Yarahmadi A, Bostani S, Yarian N, Haddad M, Lesani S Discov Oncol. 2024; 15(1):818.

PMID: 39707033 PMC: 11662135. DOI: 10.1007/s12672-024-01590-0.

Assessing Therapeutic Nanoparticle Accumulation in Tumors Using Nanobubble-Based Contrast-Enhanced Ultrasound Imaging.

Cooley M, Wegierak D, Perera R, Abenojar E, Nittayacharn P, Berg F ACS Nano. 2024; 18(48):33181-33196.

PMID: 39566912 PMC: 11619768. DOI: 10.1021/acsnano.4c11805.

Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments.

Um-E-Kalsoom , Wang S, Qu J, Liu L Cancer Med. 2024; 13(19):e70155.

PMID: 39387259 PMC: 11465031. DOI: 10.1002/cam4.70155.

The application of bacteria-nanomaterial hybrids in antitumor therapy.

Xiao S, Mu M, Feng C, Pan S, Chen N J Nanobiotechnology. 2024; 22(1):536.

PMID: 39227831 PMC: 11373302. DOI: 10.1186/s12951-024-02793-x.

References

Nakamura M, Suetsugu A, Hasegawa K, Satake T, Kunisada T, Shimizu M . Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis. Anticancer Res. 2018; 38(8):4417-4423. DOI: 10.21873/anticanres.12743. View

Perez-Medina C, Abdel-Atti D, Tang J, Zhao Y, Fayad Z, Lewis J . Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. Nat Commun. 2016; 7:11838. PMC: 4915130. DOI: 10.1038/ncomms11838. View

Granot D, Kunz-Schughart L, Neeman M . Labeling fibroblasts with biotin-BSA-GdDTPA-FAM for tracking of tumor-associated stroma by fluorescence and MR imaging. Magn Reson Med. 2005; 54(4):789-97. PMC: 1382177. DOI: 10.1002/mrm.20628. View

Laking G, Price P . Positron emission tomographic imaging of angiogenesis and vascular function. Br J Radiol. 2004; 76 Spec No 1:S50-9. DOI: 10.1259/bjr/30399077. View

Ansari C, Tikhomirov G, Hong S, Falconer R, Loadman P, Gill J . Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. Small. 2013; 10(3):566-75, 417. PMC: 3946335. DOI: 10.1002/smll.201301456. View

Feleppa E, Mamou J, Porter C, Machi J . Quantitative ultrasound in cancer imaging. Semin Oncol. 2011; 38(1):136-50. PMC: 3057450. DOI: 10.1053/j.seminoncol.2010.11.006. View

Haubner R, Wester H, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman S . Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med. 2001; 42(2):326-36. View

Niu G, Chen X . PET Imaging of Angiogenesis. PET Clin. 2010; 4(1):17-38. PMC: 2753532. DOI: 10.1016/j.cpet.2009.04.011. View

Lopes A, Casse A, Billard E, Boulcourt-Sambou E, Roche G, Larois C . Deciphering the immune microenvironment of a tissue by digital imaging and cognition network. Sci Rep. 2018; 8(1):16692. PMC: 6232093. DOI: 10.1038/s41598-018-34731-x. View

10.

Si P, Sen D, Dutta R, Yousefi S, Dalal R, Winetraub Y . In Vivo Molecular Optical Coherence Tomography of Lymphatic Vessel Endothelial Hyaluronan Receptors. Sci Rep. 2017; 7(1):1086. PMC: 5430649. DOI: 10.1038/s41598-017-01172-x. View

11.

Albatany M, Li A, Meakin S, Bartha R . In vivo detection of acute intracellular acidification in glioblastoma multiforme following a single dose of cariporide. Int J Clin Oncol. 2018; 23(5):812-819. DOI: 10.1007/s10147-018-1289-0. View

12.

Fujimoto J, Pitris C, Boppart S, Brezinski M . Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. Neoplasia. 2000; 2(1-2):9-25. PMC: 1531864. DOI: 10.1038/sj.neo.7900071. View

13.

Vilela C, Souza L, Siqueira R, Calado R, Covas D, Paula J . Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging. Stem Cell Res Ther. 2018; 9(1):155. PMC: 5998578. DOI: 10.1186/s13287-018-0909-y. View

14.

Bendinger A, Glowa C, Peter J, Karger C . Photoacoustic imaging to assess pixel-based sO2 distributions in experimental prostate tumors. J Biomed Opt. 2018; 23(3):1-11. DOI: 10.1117/1.JBO.23.3.036009. View

15.

Zhu Y, Johnson L, Huang Z, Rubin J, Yuan J, Lei H . Identifying intestinal fibrosis and inflammation by spectroscopic photoacoustic imaging: an animal study . Biomed Opt Express. 2018; 9(4):1590-1600. PMC: 5905908. DOI: 10.1364/BOE.9.001590. View

16.

Lavaud J, Henry M, Coll J, Josserand V . Exploration of melanoma metastases in mice brains using endogenous contrast photoacoustic imaging. Int J Pharm. 2017; 532(2):704-709. DOI: 10.1016/j.ijpharm.2017.08.104. View

17.

Zhang Q, Bindokas V, Shen J, Fan H, Hoffman R, Rosie Xing H . Time-course imaging of therapeutic functional tumor vascular normalization by antiangiogenic agents. Mol Cancer Ther. 2011; 10(7):1173-84. DOI: 10.1158/1535-7163.MCT-11-0008. View

18.

Vavere A, Biddlecombe G, Spees W, Garbow J, Wijesinghe D, Andreev O . A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res. 2009; 69(10):4510-6. PMC: 2690701. DOI: 10.1158/0008-5472.CAN-08-3781. View

19.

Rojas J, Papadopoulou V, Czernuszewicz T, Rajamahendiran R, Chytil A, Chiang Y . Ultrasound Measurement of Vascular Density to Evaluate Response to Anti-Angiogenic Therapy in Renal Cell Carcinoma. IEEE Trans Biomed Eng. 2018; 66(3):873-880. PMC: 6691901. DOI: 10.1109/TBME.2018.2860932. View

20.

Lo P, Chen J, Stefflova K, Warren M, Navab R, Bandarchi B . Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. J Med Chem. 2008; 52(2):358-68. PMC: 2773291. DOI: 10.1021/jm801052f. View